The science behind BPC 157 and GLP 1 agonists. One promises rapid healing, the other significant weight loss. Both tap into desires for well being. #BPC157 #GLP1 #HealthScience #Biohacking #Wellness Long Term Effects Of GLP 1 Medications: What You Should Know Glucagon Like Peptide 1 Receptor Agonists and Dual Glucose Dependent Insulinotropic Polypeptide Glucagon Like Peptide 1 Receptor Agonists in the Treatment of Obesity Metabolic Syndrome, Prediabetes Diabetes and Non Alcoholic Fatty Liver DiseaseCurrent GLP 1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add on Value of a Combined Therapy Drugs Springer Nature Link Many people remain excluded from GLP 1 clinical trials for weight loss Weight Reduction with GLP 1 Agonists and Paths for Discontinuation While Maintaining Weight Loss